SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Unum Group – ‘10-Q’ for 9/30/23 – ‘EX-31.2’

On:  Wednesday, 11/1/23, at 4:27pm ET   ·   For:  9/30/23   ·   Accession #:  5513-23-192   ·   File #:  1-11294

Previous ‘10-Q’:  ‘10-Q’ on 8/2/23 for 6/30/23   ·   Next & Latest:  ‘10-Q’ on 5/1/24 for 3/31/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

11/01/23  Unum Group                        10-Q        9/30/23   94:28M

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   6.19M 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     30K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     30K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     27K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     27K 
11: R1          Document and Entity Information                     HTML     84K 
12: R2          Consolidated Balance Sheets                         HTML    142K 
13: R3          Consolidated Balance Sheets (Parenthetical)         HTML     51K 
14: R4          Consolidated Statements of Income (Unaudited)       HTML    115K 
15: R5          Consolidated Statements of Comprehensive Income     HTML     62K 
16: R6          Statement of Comprehensive Income (Parenthetical)   HTML     40K 
17: R7          Consolidated Statements of Stockholders' Equity     HTML     73K 
18: R8          Consolidated Statements of Stockholders' Equity     HTML     28K 
                (Parenthetical)                                                  
19: R9          Consolidated Statements of Cash Flows (Unaudited)   HTML    119K 
20: R10         Basis of Presentation                               HTML     29K 
21: R11         Accounting Developments                             HTML    285K 
22: R12         Fair Values of Financial Instruments                HTML    552K 
23: R13         Investments                                         HTML    627K 
24: R14         Derivative Financial Instruments                    HTML    230K 
25: R15         Accumulated Other Comprehensive Income (Loss)       HTML    148K 
26: R16         Liability for Future Policy Benefits,               HTML    762K 
                Policyholder's Account Balances, and Deferred                    
                Acquisition Costs                                                
27: R17         Segment Information                                 HTML    214K 
28: R18         Employee Benefit Plans                              HTML     84K 
29: R19         Stockholders' Equity and Earnings Per Common Share  HTML     76K 
30: R20         Commitments and Contingent Liabilities              HTML     33K 
31: R21         Other                                               HTML     35K 
32: R22         Pay vs Performance Disclosure                       HTML     38K 
33: R23         Insider Trading Arrangements                        HTML     36K 
34: R24         Basis of Presentation (Policies)                    HTML     28K 
35: R25         Liability for Future Policy Benefits,               HTML     42K 
                Policyholder's Account Balances, and Deferred                    
                Acquisition Costs (Policies)                                     
36: R26         Accounting Changes and Error Corrections (Tables)   HTML    268K 
37: R27         Fair Values of Financial Instruments (Tables)       HTML    480K 
38: R28         Investments (Tables)                                HTML    619K 
39: R29         Derivative Financial Instruments (Tables)           HTML    223K 
40: R30         Accumulated Other Comprehensive Income (Loss)       HTML    149K 
                (Tables)                                                         
41: R31         Liability for Future Policy Benefits,               HTML    741K 
                Policyholder's Account Balances, and Deferred                    
                Acquisition Costs (Tables)                                       
42: R32         Segment Information (Tables)                        HTML    213K 
43: R33         Employee Benefit Plans (Tables)                     HTML     79K 
44: R34         Stockholders' Equity and Earnings Per Common Share  HTML     67K 
                (Tables)                                                         
45: R35         Accounting Developments (Details)                   HTML    562K 
46: R36         Fair Values of Financial Instruments Private        HTML     61K 
                Equity Partnerships (Details)                                    
47: R37         Fair Value Measurements by Input Level (Detail)     HTML    163K 
48: R38         Changes in Assets and Liabilities Measured at Fair  HTML    127K 
                Value on a Recurring Basis using Significant                     
                Unobservable Inputs (Level 3) (Detail)                           
49: R39         Quantitative Information Regarding Significant      HTML     58K 
                Unobservable Inputs (Details)                                    
50: R40         Fair Values of Financial Instruments Carrying       HTML     74K 
                Amounts and Estimated Fair value of Financial                    
                Instruments Not Measured at Fair Value (Details)                 
51: R41         Fair Value of Financial Instruments Additional      HTML     43K 
                Information (Detail)                                             
52: R42         Amortized Cost and Fair Values of Securities by     HTML     82K 
                Security Type (Detail)                                           
53: R43         Length of Time Fixed Maturity Securities had been   HTML     66K 
                in a Gross Unrealized Loss Position (Detail)                     
54: R44         Investments Distribution of the Maturity Dates for  HTML    102K 
                Fixed Maturity Securities (Details)                              
55: R45         Investments Distribution by External Credit Rating  HTML     46K 
                for Fixed Maturity Securities (Details)                          
56: R46         Debt Securities, Available-for-sale, Allowance for  HTML     38K 
                Credit Losses Rollforward (Details)                              
57: R47         Mortgage Loans by Property Type and Geographic      HTML     64K 
                Region (Detail)                                                  
58: R48         Schedule of Participating Mortgage Loans by         HTML     50K 
                Internal Credit Rating and Loan to Value (Details)               
59: R49         Mortgage Loans, Sorted by Applicable Credit         HTML    141K 
                Quality Indicators (Detail)                                      
60: R50         Mortgage Loans, Allowance for Credit Losses         HTML     64K 
                Rollforward (Details)                                            
61: R51         Investments Remaining Contractual Maturity of       HTML     45K 
                Secruity Lending Agreements (Details)                            
62: R52         Investments Federal Home Loan Bank Carrying         HTML     37K 
                Amount, Collateral Posted and Advances Received                  
                (Details)                                                        
63: R53         Investments Schedule of Financial Instrument and    HTML    148K 
                Derivative Offsetting (Details)                                  
64: R54         Investments Investment Income (Detail)              HTML     65K 
65: R55         Investment Gains and Losses Reported in             HTML     52K 
                Consolidated Statements of Income (Detail)                       
66: R56         Investments - Additional Information (Detail)       HTML    137K 
67: R57         Derivative Financial Instruments Nature and Amount  HTML     47K 
                of Collateral Received From and Posted To Our                    
                Derivative Counterparties (Details)                              
68: R58         Derivative Financial Instruments Fair Value Hedges  HTML     38K 
                Carrying Amount of Hedged Assets and Liabilities                 
                and Cumulative Basis Adjustments (Details)                       
69: R59         Location and Fair Values of Derivative Financial    HTML     79K 
                Instruments (Detail)                                             
70: R60         Derivative Financial Instruments Location of Gains  HTML     67K 
                and Losses Designated as Hedging Instruments,                    
                Consolidated Statements of Income (Details)                      
71: R61         Location of Gains and Losses on Derivative          HTML     37K 
                Instruments Designated as Cash Flow Hedging                      
                Instruments (Detail)                                             
72: R62         Gains and Losses on Derivatives Not Designated as   HTML     38K 
                Hedging Instruments (Detail)                                     
73: R63         Derivative Financial Instruments - Additional       HTML     74K 
                Information (Detail)                                             
74: R64         Schedule of Accumulated Other Comprehensive Income  HTML     77K 
                (Loss) (Details)                                                 
75: R65         Schedule of Reclassifications Out of Accumulated    HTML     80K 
                Other Comprehensive Income (Details)                             
76: R66         Liability for Future Policy Benefit Activity        HTML    466K 
                (Details)                                                        
77: R67         Policyholder Account Balance (Details)              HTML    101K 
78: R68         Policyholder Account Balance, Guaranteed Minimum    HTML    165K 
                Crediting (Details)                                              
79: R69         Deferred Policy Acquisition Costs (Details)         HTML     73K 
80: R70         Premium Income by Major Line of Business within     HTML     75K 
                Each Segment (Detail)                                            
81: R71         Selected Operating Statement Data by Segment        HTML     63K 
                (Detail)                                                         
82: R72         Assets by Segment (Detail)                          HTML     47K 
83: R73         Reconciliation of Total Revenue and Income Before   HTML     56K 
                Income Tax to Operating Revenue and Operating                    
                Income (Detail)                                                  
84: R74         Segment Information Segments - Additional           HTML     28K 
                Information (Detail)                                             
85: R75         Employee Benefit Plans Net Periodic Benefit Cost    HTML     57K 
                (Detail)                                                         
86: R76         Basic and Diluted Earnings Per Share (Detail)       HTML     62K 
87: R77         Treasury Stock Transactions (Details)               HTML     39K 
88: R78         Stockholders' Equity and Earnings Per Common Share  HTML     58K 
                - Additional Information (Detail)                                
89: R79         Allowance for Expected Credit Losses on Premiums    HTML     34K 
                Receivable (Details)                                             
92: XML         IDEA XML File -- Filing Summary                      XML    172K 
90: XML         XBRL Instance -- unm-20230930_htm                    XML  10.31M 
91: EXCEL       IDEA Workbook of Financial Report Info              XLSX    334K 
 7: EX-101.CAL  XBRL Calculations -- unm-20230930_cal                XML    231K 
 8: EX-101.DEF  XBRL Definitions -- unm-20230930_def                 XML   1.39M 
 9: EX-101.LAB  XBRL Labels -- unm-20230930_lab                      XML   2.90M 
10: EX-101.PRE  XBRL Presentations -- unm-20230930_pre               XML   1.84M 
 6: EX-101.SCH  XBRL Schema -- unm-20230930                          XSD    257K 
93: JSON        XBRL Instance as JSON Data -- MetaLinks              776±  1.18M 
94: ZIP         XBRL Zipped Folder -- 0000005513-23-000192-xbrl      Zip    788K 


‘EX-31.2’   —   Certification — §302 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:   C: 
  Document  

EXHIBIT 31.2

CERTIFICATION

I, Steven A. Zabel, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Unum Group;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


Date: November 1, 2023/s/ Steven A. Zabel
Steven A. Zabel
Executive Vice President, Chief Financial Officer

A signed original of this written statement required by Section 302 of the Sarbanes-Oxley Act of 2002 has been provided to Unum Group and will be retained by Unum Group and furnished to the Securities and Exchange Commission or its staff upon request.


Dates Referenced Herein

This ‘10-Q’ Filing    Date    Other Filings
Filed on:11/1/23None on these Dates
For Period end:9/30/23
 List all Filings 
Top
Filing Submission 0000005513-23-000192   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 5:01:56.1pm ET